Methicillin-resistant Staphylococcus aureus in the ICU: risk factors and a predictive model to detect it at ICU admission

por Callejo-Torre, F, Eiros, JM, Ossa-Echeverri, S, Olaechea, P, Palomar, M, Alvarez-Lerma, F, Group, Envin-Helics Study
Publicado 2015

Is it possible to predict multidrug-resistant organism colonization and/or infection at ICU admission?

por Callejo-Torre, F, Eiros, JM, Ossa-Echeverri, S, Olaechea, P, Alvarez-Lerma, F, Palomar, M, Group, Envin-Helics Study
Publicado 2015

Short-term outcomes after repair treatment (clipping or coiling) in aneurysmal subarachnoid hemorrhage (ASAH): a prospective multicenter study

por Gero Escapa, M, Iglesias Posadilla, D, González Robledo, J, Domínguez Berrot, A, González Salamanca, A, Nogales Martín, L, Ossa Echeverri, S, Diego Calvo, A, Riesco Crespo, M, Olmos Linares, AM, Bueno Sacristán, A, Ranedo Zaldo, R
Publicado 2015

Health-related medium term quality of life in intermediate risk pulmonary embolism in a general icu

por Portugal Rodríguez, E, Del Valle Ortiz, M, Badallo Arévalo, O, Ayuela Azcárate, JM, Martínez Barrio, E, Berrazueta Sánchez de Vega, A, Gero Escapa, M, Fernández Ratero, JA, Ossa Echeverri, SA, Perea Rodríguez, ME, Carbajales Pérez, C
Publicado 2015

Multi-resistant pseudomonas aeruginosa: study of risk factors for its detection at intensive care unit admission

por Puerto Corrales, S, Vara Arlanzón, R, Callejo-Torre, F, Eiros Bouza, JM, Coma del Corral, MJ, Perea Rodríguez, ME, Martínez Barrios, M, Gero Escapa, M, Ossa Echeverri, S, del Valle Ortíz, M, Calvo Simal, S, Portugal Rodríguez, E, Fernández Ratero, JA
Publicado 2015

Risk factors at icu admission for multi-resistant acinetobacter baumannii colonization and infection and its prediction capability

por Vara Arlanzón, R, Puerto Corrales, S, Callejo-Torre, F, Eiros Bouza, JM, Coma del Corral, MJ, Martínez Barrios, M, Perea Rodríguez, ME, Montero Baladía, M, Ossa Echeverri, S, Calvo Simal, S, del Valle Ortíz, M, Badallo Arévalo, O, Carbajales Pérez, C, Fernández Ratero, JA
Publicado 2015

Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients

por Luis, Buzon-Martín, Miguel, Montero-Baladía, Pedro, Delgado-López, David, Iglesias-Posadilla, Itziar, Astigarraga, Ana, Galacho-Harriero, Enrique, Iglesias-Julián, María, López-Veloso, Noelia, De La Torre-Ferrera, Julio César, Barraza-Bengoechea, Marta, Ubeira- Iglesias, Rodrigo, San Llorente- Sebastián, María, Colazo-Burlato, Andrés, Lorenzo-Martín, Javier, Minguito de la Iglesia, Juan Pablo, García-Muñoz, Gerardo, Hermida-Fernández, Carolina, Navarro-San Francisco, Jorge, Boado-Lama, María, Fernández-Regueras, Fernando, Callejo-Torre, Sergio, Ossa-Echeverri, Lourdes, Fisac-Cuadrado, María, Gero-Escapa, Gregoria, Megías-Lobón, Adolfo, Simón-Rodríguez, José Antonio, Fernández-Ratero
Publicado 2021